Data on Membranous Nephropathy Described by Researchers at Nanchang University (Apc Ameliorates Idiopathic Membranous Nephropathy By Affecting Podocyte Apoptosis Through the Erk1/2/yb-1/pla2r1 Axis).

Researchers at Nanchang University in Jiangxi, China, have conducted a study on idiopathic membranous nephropathy (IMN), a type of kidney disease. The study focused on the role of activated protein C (APC) in affecting podocyte apoptosis through the ERK1/2/YB-1/PLA2R1 axis. The findings suggest that APC may offer a new targeted therapy for IMN patients with high PLA2R1 expression. This research has been peer-reviewed and provides valuable insights into potential treatments for this condition. [Extracted from the article]